InvestorsHub Logo

bidmark

12/17/20 9:47 AM

#315798 RE: hump4 #315797

Just curious if Nissen used corn or mineral oil in his sour grape trial!

yudilks

12/17/20 10:04 AM

#315799 RE: hump4 #315797

Is this why AMRN drop another 3%?

Retired2019

12/17/20 10:29 AM

#315800 RE: hump4 #315797

This is just old news, more repeat nonsense. They wish they owned Vascepa and roles were reversed. Then, they be touting V as a wonder drug.....

money_man

12/17/20 10:32 AM

#315801 RE: hump4 #315797

If I see another talking head refer to Icosapent Ethyl as fish oil I'm going to lose it. He then goes on to call Vascepa "costly." Yes, $9 for 90 days supply is outrageous. Every poster on this message board should be emailing this to investor relations and also replying to the author (his email is listed at the top of the article) to inform him of the misleading information contained in his article. What. a. joke.

couldbebetter

12/17/20 10:35 AM

#315802 RE: hump4 #315797

Nissen is not stupid...he is evil. His disproven comments on mineral oil
are intentional. Are they sour grapes from his failed Epanova study...or
are they being made because some BP wants to keep a cap on AMRN stock?
I hope AMRN sues both Nissen as well as the Cleveland Clinic. AMRN
should consider running adds targeting patients of the Cleveland Clinic
which would ask if they were denied the CV medication Vascepa and had
an event...then recommend an attorney for advice. The only way to fight
this is for AMRN to play hardball and be aggressive in the protection
of Vascepa and CVD patients.

lizzy241

12/17/20 11:19 AM

#315810 RE: hump4 #315797

hump4, I sent the article to IR. I doubt if they'll respond to the authors' inaccuracies.